Related Experiment Videos
Monoclonal antibodies reactive with small cell carcinoma of the lung
Abstract:
Murine monoclonal antibodies (MoAb) reactive with antigens associated with small cell carcinoma of the lung (SCCL) were prepared and partially characterized. Four were selected for further study on the basis of their lack of reactivity with normal leukocytes and erythrocytes. These MoAb, designated SCCL-41, SCCL-114, SCCL-124, and SCCL-175, are all IgM immunoglobulins. The binding of these MoAb to patient-derived SCCL tumor cells, SCCL cell lines, and non-SCCL cell lines was studied by indirect immunofluorescence and flow cytometry. Considerable heterogeneity in the expression of these cell surface antigens was noted among both the patient-derived tumor cells and the SCCL cell lines. One of the MoAb, SCCL-175, reacted with 7 of 7 patient-derived tumor cell samples and 9 of 10 SCCL cell lines. None of the antigens defined by these MoAb were expressed on non-SCCL lung tumor cell lines. SCCL-175 reacted with cells from both a choriocarcinoma and a colon carcinoma cell line, whereas the other 3 MoAb were unreactive with these and several other tumor cell lines. These MoAb may be useful in the diagnosis and subclassification of SCCL tumors.
Insights
Researchers developed murine monoclonal antibodies (MoAb) to identify small cell lung cancer (SCLC) antigens. One MoAb, SCCL-175, showed high reactivity with SCLC cells, suggesting diagnostic potential.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- Small cell carcinoma of the lung (SCCL) is an aggressive form of lung cancer.
- Development of specific diagnostic markers for SCCL is crucial for effective treatment.
- Murine monoclonal antibodies (MoAb) offer high specificity for targeted antigen detection.
Purpose of the Study:
- To generate and characterize murine monoclonal antibodies (MoAb) targeting antigens specific to small cell carcinoma of the lung (SCCL).
- To evaluate the reactivity of these MoAb against SCCL cell lines and patient-derived tumor samples.
- To assess the potential utility of these MoAb in the diagnosis and subclassification of SCCL.
Main Methods:
- Production and partial characterization of murine monoclonal antibodies (MoAb).
- Selection of MoAb based on specificity for SCCL antigens and lack of reactivity with normal blood cells.
- Assessment of MoAb binding to tumor cells using indirect immunofluorescence and flow cytometry.
Main Results:
- Four IgM MoAb (SCCL-41, SCCL-114, SCCL-124, SCCL-175) were identified.
- Significant heterogeneity in antigen expression was observed across SCCL samples.
- MoAb SCCL-175 demonstrated high reactivity with 7/7 patient SCCL samples and 9/10 SCCL cell lines.
- Antigens were specific to SCCL, with no reactivity on non-SCCL lung cancer cell lines.
- SCCL-175 also reacted with choriocarcinoma and colon carcinoma cell lines, unlike other MoAb.
Conclusions:
- The developed MoAb, particularly SCCL-175, recognize antigens associated with small cell lung cancer.
- These MoAb exhibit specificity for SCCL, with SCCL-175 showing promising reactivity.
- The findings suggest that these MoAb could be valuable tools for the diagnosis and subclassification of SCCL.